These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


198 related items for PubMed ID: 8890164

  • 1. Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells.
    Cloutier JF, Veillette A.
    EMBO J; 1996 Sep 16; 15(18):4909-18. PubMed ID: 8890164
    [Abstract] [Full Text] [Related]

  • 2. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
    Wang B, Lemay S, Tsai S, Veillette A.
    Mol Cell Biol; 2001 Feb 16; 21(4):1077-88. PubMed ID: 11158295
    [Abstract] [Full Text] [Related]

  • 3. Inhibitory tyrosine protein kinase p50csk is associated with protein-tyrosine phosphatase PTP-PEST in hemopoietic and non-hemopoietic cells.
    Davidson D, Cloutier JF, Gregorieff A, Veillette A.
    J Biol Chem; 1997 Sep 12; 272(37):23455-62. PubMed ID: 9287362
    [Abstract] [Full Text] [Related]

  • 4. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase.
    Cloutier JF, Veillette A.
    J Exp Med; 1999 Jan 04; 189(1):111-21. PubMed ID: 9874568
    [Abstract] [Full Text] [Related]

  • 5. Domain interactions in protein tyrosine kinase Csk.
    Sondhi D, Cole PA.
    Biochemistry; 1999 Aug 24; 38(34):11147-55. PubMed ID: 10460171
    [Abstract] [Full Text] [Related]

  • 6. Sequence requirements for association of protein-tyrosine phosphatase PEP with the Src homology 3 domain of inhibitory tyrosine protein kinase p50(csk).
    Gregorieff A, Cloutier JF, Veillette A.
    J Biol Chem; 1998 May 22; 273(21):13217-22. PubMed ID: 9582365
    [Abstract] [Full Text] [Related]

  • 7. Molecular cloning of lsk, a carboxyl-terminal src kinase (csk) related gene, expressed in leukocytes.
    McVicar DW, Lal BK, Lloyd A, Kawamura M, Chen YQ, Zhang X, Staples JE, Ortaldo JR, O'Shea JJ.
    Oncogene; 1994 Jul 22; 9(7):2037-44. PubMed ID: 7516063
    [Abstract] [Full Text] [Related]

  • 8. The Src and Csk families of tyrosine protein kinases in hemopoietic cells.
    Chow LM, Veillette A.
    Semin Immunol; 1995 Aug 22; 7(4):207-26. PubMed ID: 8520026
    [Abstract] [Full Text] [Related]

  • 9. Recruitment of C-terminal Src kinase by the leukocyte inhibitory receptor CD85j.
    Sayós J, Martínez-Barriocanal A, Kitzig F, Bellón T, López-Botet M.
    Biochem Biophys Res Commun; 2004 Nov 12; 324(2):640-7. PubMed ID: 15474475
    [Abstract] [Full Text] [Related]

  • 10. Requirement of the SH3 and SH2 domains for the inhibitory function of tyrosine protein kinase p50csk in T lymphocytes.
    Cloutier JF, Chow LM, Veillette A.
    Mol Cell Biol; 1995 Nov 12; 15(11):5937-44. PubMed ID: 7565746
    [Abstract] [Full Text] [Related]

  • 11. Novel mechanism of regulation of the non-receptor protein tyrosine kinase Csk: insights from NMR mapping studies and site-directed mutagenesis.
    Shekhtman A, Ghose R, Wang D, Cole PA, Cowburn D.
    J Mol Biol; 2001 Nov 16; 314(1):129-38. PubMed ID: 11724538
    [Abstract] [Full Text] [Related]

  • 12. C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases.
    Chong YP, Mulhern TD, Cheng HC.
    Growth Factors; 2005 Sep 16; 23(3):233-44. PubMed ID: 16243715
    [Abstract] [Full Text] [Related]

  • 13. Proline-rich sequences mediate the interaction of the Arg protein tyrosine kinase with Crk.
    Wang B, Mysliwiec T, Feller SM, Knudsen B, Hanafusa H, Kruh GD.
    Oncogene; 1996 Oct 03; 13(7):1379-85. PubMed ID: 8875975
    [Abstract] [Full Text] [Related]

  • 14. A novel, specific interaction involving the Csk SH3 domain and its natural ligand.
    Ghose R, Shekhtman A, Goger MJ, Ji H, Cowburn D.
    Nat Struct Biol; 2001 Nov 03; 8(11):998-1004. PubMed ID: 11685249
    [Abstract] [Full Text] [Related]

  • 15. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.
    Summy JM, Guappone AC, Sudol M, Flynn DC.
    Oncogene; 2000 Jan 06; 19(1):155-60. PubMed ID: 10644991
    [Abstract] [Full Text] [Related]

  • 16. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
    Cheng HC, Bjorge JD, Aebersold R, Fujita DJ, Wang JH.
    Biochemistry; 1996 Sep 10; 35(36):11874-87. PubMed ID: 8794770
    [Abstract] [Full Text] [Related]

  • 17. Hydrophobic interaction between the SH2 domain and the kinase domain is required for the activation of Csk.
    Mikkola ET, Gahmberg CG.
    J Mol Biol; 2010 Jun 18; 399(4):618-27. PubMed ID: 20434462
    [Abstract] [Full Text] [Related]

  • 18. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins.
    Karlsson T, Songyang Z, Landgren E, Lavergne C, Di Fiore PP, Anafi M, Pawson T, Cantley LC, Claesson-Welsh L, Welsh M.
    Oncogene; 1995 Apr 20; 10(8):1475-83. PubMed ID: 7537362
    [Abstract] [Full Text] [Related]

  • 19. Structural basis for domain-domain communication in a protein tyrosine kinase, the C-terminal Src kinase.
    Lin X, Wang Y, Ahmadibeni Y, Parang K, Sun G.
    J Mol Biol; 2006 Apr 07; 357(4):1263-73. PubMed ID: 16483606
    [Abstract] [Full Text] [Related]

  • 20. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.
    Moarefi I, LaFevre-Bernt M, Sicheri F, Huse M, Lee CH, Kuriyan J, Miller WT.
    Nature; 1997 Feb 13; 385(6617):650-3. PubMed ID: 9024665
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.